Effectiveness of Tocilizumab in Patients with Severe or Critical Lung Involvement in COVID-19: A Retrospective Study

Effectiveness of Tocilizumab in Patients with Severe or Critical Lung Involvement in COVID-19: A Retrospective Study

Introduction: Acute lung injury is associated with dysfunctional immune response to SARS-CoV-2. This leads to CRS, which require immunomodulatory treatments aiming to limit the excessive production of cytokines. The literature so far indicates the effectiveness of tocilizumab in patients with COVID-...

Full description

Bibliographic Details
Main Authors: Daniel Chober, Bogusz Aksak-Wąs, Katarzyna Bobrek-Lesiakowska, Anna Budny-Finster, Ewa Hołda, Joanna Mieżyńska-Kurtycz, Grzegorz Jamro, Miłosz Parczewski
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Journal of Clinical Medicine
Subjects:
COVID-19
SARS-CoV-2
tocilizumab
mortality
dexamethasone
ICU
Online Access:https://www.mdpi.com/2077-0383/11/9/2286

Internet

https://www.mdpi.com/2077-0383/11/9/2286

Similar Items